Amgen Honored for Best Pipeline & Best New Drug

Publication
Article
Oncology & Biotech NewsDecember 2009
Volume 0

Articles in this issue
Amgen Honored for Best Pipeline & Best New Drug
Do Insurers Spend Too Much on Administration and Too Little on Care?
The Effect of New Treatments on Cancer-related Bone Loss
Exercise Maintains Function, Improves QoL for Patients With Lymphoma
Continuing Education Opportunities on the Web
Ramucirumab (IMC-1121B): A Novel Fully Human Monoclonal Antibody that Targets VEGFR-2
News Briefs & FDA Updates
News & Opinion
Decline in Cancer Deaths No Reason to Get Complacent
Related Videos
Related Content
Maurie Markman, MD

The Critical Nature of Decision-Making in the Development of Phase 3 Clinical Trials

April 12th 2024
Article
Sorting Through Sexism, Guilt, and Motherhood in Medicine

Sorting Through Sexism, Guilt, and Motherhood in Medicine

January 27th 2022
Podcast
Eduardo M. Sotomayor, MD

Tampa General Hospital Cancer Institute Celebrates 2 Years of Growth and Innovation

January 19th 2024
Article
Gilbert on Gaining New Ground at Vanderbilt

Gilbert on Gaining New Ground at Vanderbilt

January 3rd 2022
Podcast
Jason Westin, MD

Westin Testifies to Senate Finance Committee on Cancer Drug Shortage

December 5th 2023
Article
Naveen Pemmaraju, MD

New Developments in MPN Management Provide Additional Options for Patients

December 5th 2023
Article